Aims

The Jorjani Biomedicine Journal (JBJ) is a premier, peer-reviewed, open-access publication dedicated to advancing the frontiers of medical knowledge and public health. Named in honor of the distinguished Persian physician Ismail Jorjani, the journal embodies a spirit of inquiry that bridges classical medical wisdom with cutting-edge modern science.

   JBJ aims to serve as a critical platform for the dissemination of high-quality, evidence-based research that addresses pressing health challenges. We are committed to fostering interdisciplinary collaboration among epidemiologists, basic scientists, molecular biologists, clinicians, and public health professionals. Our ultimate goal is to translate scientific discovery into tangible improvements in clinical practice, health policy, and patient outcomes on a global scale.

Scope
The Jorjani Biomedicine Journal (JBJ) publishes original research, systematic reviews, meta-analyses, and brief communications that fall within, but are not limited to, the following core pillars of biomedical science:

1. Biostatistics and Epidemiology

• Development and application of novel statistical methodologies in health research.

• Observational and interventional epidemiological studies focusing on disease etiology, risk factors, and transmission dynamics.

• Genetic and molecular epidemiology.

• Health data science, including the use of machine learning and AI in predictive modeling and public health surveillance.

• Clinical trial design and analysis.

2. Basic Medical Sciences

• Physiological and pathophysiological mechanisms of disease at the organ and systemic levels.

• Anatomical, histopathological, and biochemical investigations.

• Pharmacology and toxicology, including drug discovery, pharmacokinetics, and pharmacodynamics.

• Microbiology, immunology, and host-pathogen interactions.

• Comparative medicine and animal models of human disease.

3. Molecular Sciences

• Genomics, proteomics, transcriptomics, and metabolomics.

• Molecular mechanisms of cell signaling, apoptosis, and autophagy.

• Cancer biology and oncology at the molecular level.

• Epigenetics and gene regulation.

• Molecular diagnostics and biomarker discovery.

• Nanobiotechnology and its biomedical applications.

4. Clinical Sciences

• Clinical trials and outcomes research across all medical specialties (e.g., cardiology, neurology, endocrinology, gastroenterology, infectious diseases).

• Case series and reports on novel clinical manifestations or treatments.

• Translational research that moves discoveries from bench to bedside.

• Diagnostic and therapeutic innovations, including surgical techniques and medical devices.

• Evidence-based clinical practice guidelines and decision-making.

5. Health

• Public health policy, health promotion, and disease prevention.

• Social and behavioral determinants of health.

• Environmental and occupational health.

• Health economics, health services research, and healthcare management.

• Global health issues and health inequities.

• Mental health, geriatric health, and lifestyle medicine.

---

Article Types
JBJ welcomes the following types of manuscripts:

• Original Research Articles

• Systematic Reviews and Meta-Analyses

• Narrative Reviews and Mini-Reviews (by invitation or proposal)

• Short Communications and Brief Reports

• Case Reports (with significant clinical or scientific value)

• Study Protocols

• Editorials and Letters to the Editor

---

Editorial Policy
All submissions undergo a rigorous double-blind peer-review process to ensure scientific integrity, validity, and originality. The journal adheres to the highest standards of publication ethics as set by the Committee on Publication Ethics (COPE).